Reports on California-based genomics pioneer Incyte Genomics Inc.'s plan to disband its custom genomics and microarray businesses and instead focus on gene-database subscription and on leveraging its intellectual property. Number of employees who stand to lose their jobs as a result of the closures; Continued growth of the company's database revenue; Incyte's lack of interest in becoming a full-fledged drug developer.